Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 6
2004 3
2005 5
2006 8
2007 1
2008 4
2009 6
2010 6
2011 1
2013 2
2015 1
2017 1
2018 1
2019 4
2020 3
2021 4
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Targeting anti-cancer agents to bone using bisphosphonates.
Xing L, Ebetino FH, Boeckman RK Jr, Srinivasan V, Tao J, Sawyer TK, Li J, Yao Z, Boyce BF. Xing L, et al. Among authors: sawyer tk. Bone. 2020 Sep;138:115492. doi: 10.1016/j.bone.2020.115492. Epub 2020 Jun 23. Bone. 2020. PMID: 32585321 Free PMC article. Review.
Novel chemistry for undruggable targets.
Milletti F, Sawyer TK. Milletti F, et al. Among authors: sawyer tk. Eur J Med Chem. 2015 Apr 13;94:458. doi: 10.1016/j.ejmech.2015.02.015. Epub 2015 Feb 13. Eur J Med Chem. 2015. PMID: 25735718 No abstract available.
AILERON Therapeutics.
Sawyer TK. Sawyer TK. Chem Biol Drug Des. 2009 Jan;73(1):3-6. doi: 10.1111/j.1747-0285.2008.00744.x. Chem Biol Drug Des. 2009. PMID: 19152629 No abstract available.
Future anti-catabolic therapeutic targets in bone disease.
Boyce BF, Xing L, Yao Z, Shakespeare WC, Wang Y, Metcalf CA 3rd, Sundaramoorthi R, Dalgarno DC, Iuliucci JD, Sawyer TK. Boyce BF, et al. Among authors: sawyer tk. Ann N Y Acad Sci. 2006 Apr;1068:447-57. doi: 10.1196/annals.1346.042. Ann N Y Acad Sci. 2006. PMID: 16831942 Review.
Novel bone-targeted Src tyrosine kinase inhibitor drug discovery.
Shakespeare WC, Metcalf CA 3rd, Wang Y, Sundaramoorthi R, Keenan T, Weigele M, Bohacek RS, Dalgarno DC, Sawyer TK. Shakespeare WC, et al. Among authors: sawyer tk. Curr Opin Drug Discov Devel. 2003 Sep;6(5):729-41. Curr Opin Drug Discov Devel. 2003. PMID: 14579523 Review.
NanoClick: A High Throughput, Target-Agnostic Peptide Cell Permeability Assay.
Peier A, Ge L, Boyer N, Frost J, Duggal R, Biswas K, Edmondson S, Hermes JD, Yan L, Zimprich C, Sadruddin A, Kristal Kaan HY, Chandramohan A, Brown CJ, Thean D, Lee XE, Yuen TY, Ferrer-Gago FJ, Johannes CW, Lane DP, Sherborne B, Corona C, Robers MB, Sawyer TK, Partridge AW. Peier A, et al. Among authors: sawyer tk. ACS Chem Biol. 2021 Feb 19;16(2):293-309. doi: 10.1021/acschembio.0c00804. Epub 2021 Feb 4. ACS Chem Biol. 2021. PMID: 33539064
SRC inhibitors in metastatic bone disease.
Boyce BF, Xing L, Yao Z, Yamashita T, Shakespeare WC, Wang Y, Metcalf CA 3rd, Sundaramoorthi R, Dalgarno DC, Iuliucci JD, Sawyer TK. Boyce BF, et al. Among authors: sawyer tk. Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6291s-6295s. doi: 10.1158/1078-0432.CCR-06-0991. Clin Cancer Res. 2006. PMID: 17062716 Review.
SRC homology-2 inhibitors: peptidomimetic and nonpeptide.
Sawyer TK, Bohacek RS, Dalgarno DC, Eyermann CJ, Kawahata N, Metcalf CA 3rd, Shakespeare WC, Sundaramoorthi R, Wang Y, Yang MG. Sawyer TK, et al. Mini Rev Med Chem. 2002 Oct;2(5):475-88. doi: 10.2174/1389557023405765. Mini Rev Med Chem. 2002. PMID: 12370048 Review.
64 results